India-focussed US entities' lobby bill reach $212m in 2012

Tags: India, Lobby, US, News
A handful of about 20 US-based companies and industry bodies spent more than $200

RELATED ARTICLES

million (over Rs 1,000 crore) during 2012 on lobbying among the American lawmakers for their Indian business interests and other issues affecting their businesses globally.

The year-end lobbying disclosures of these companies, which are part of the Congressional records with the US Senate and the House of Representatives, come at a time when global retail giant Wal-Mart's lobbying in the US for access to Indian market is being probed by the Indian government.

An analysis of thousands of lobby disclosure reports filed by the US-based lobbyists here every quarter shows that India-focussed issues figured in the lobbying activities of at least 17 entities during 2012, along with other topics.

Together, these 17 entities, which include companies as well as industry bodies, paid a total amount of $212 million (about Rs 1,100 crore) to their lobbyists.

Among these, entities like Biotechnology Industry Association, Aerospace Industries Association of America, Dell Inc, Alcatel-Lucent, Alliance of Automobile Manufacturers, Business Software Alliance, Chamber of Commerce of the USA, Pfizer and Colgate Palmolive lobbied for India-focussed issues in the last quarter ended December 31, 2012 as well.

The Indian government has launched a probe into Wal-Mart's US lobbying for seeking access to India. The retail giant, which also continued to lobby for Indian market in the last quarter, has spent more than USD 34 million on its various lobbying activities in the US since 2008, when it began lobbying for Indian market access as well.

Lobbying is a legal activity in the US, but the lobby firms hired by the corporate entities need to make quarterly disclosures about their activities and payments. However, there are no specific regulations about lobbying in India.

The Indian government itself has a lobby firm presenting its case with the American lawmakers, while a number of Indian companies and entities also indulge in lobbying activities in the US through their respective lobbyists.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

FC NEWSLETTER

Stay informed on our latest news!

EDITORIAL OF THE DAY

  • Daiichi’s legal move against Ranbaxy’s ex-promoters will set precedence

    Daiichi Sankyo’s decision to take the former promoters of Ranbaxy to court is welcome move.

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Roopen Roy

Where is the Charging Bull headed to?

On a balmy spring morning last week, I was admiring ...

Rajgopal Nidamboor

The disdainful wrath of greed

It is rightly said that money isn’t the root of ...

Gautam Gupta

Immense potential of e-commerce in fashion and apparel

Michael Aldrich launched online shopping in1979 with no clue whatsoever ...